Frost & Sullivan Independent Equity Research

BioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged

bioline

Company: BioLineRx        

Sector: Pharmaceuticals

Report type: Immediate Report

For all past reports click here

Published on: July 30th, 2017

View Fullscreen

Download full report